BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30404270)

  • 1. The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing.
    Bissonnette L; Bergeron MG
    Micromachines (Basel); 2016 May; 7(6):. PubMed ID: 30404270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Opportunities of Centrifugal Microfluidics for Extreme Point-of-Care Testing.
    Michael IJ; Kim TH; Sunkara V; Cho YK
    Micromachines (Basel); 2016 Feb; 7(2):. PubMed ID: 30407405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
    Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
    Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nucleic acid testing devices to diagnose infectious diseases in resource-limited settings.
    Maffert P; Reverchon S; Nasser W; Rozand C; Abaibou H
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1717-1731. PubMed ID: 28573472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fully integrated hand-powered centrifugal microfluidic platform for ultra-simple and non-instrumental nucleic acid detection.
    Li M; Ge A; Liu M; Ma B; Ma C; Shi C
    Talanta; 2020 Nov; 219():121221. PubMed ID: 32887122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by Recombinase Polymerase Amplification.
    Law ILG; Loo JFC; Kwok HC; Yeung HY; Leung CCH; Hui M; Wu SY; Chan HS; Kwan YW; Ho HP; Kong SK
    Anal Biochem; 2018 Mar; 544():98-107. PubMed ID: 29305096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for overcoming challenges for decentralised diagnostics in resource-limited and catastrophe settings.
    Sharma S; Crawley A; O'Kennedy R
    Expert Rev Mol Diagn; 2017 Feb; 17(2):109-118. PubMed ID: 28010145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD-Based Microfluidics for Primary Care in Extreme Point-of-Care Settings.
    Smith S; Mager D; Perebikovsky A; Shamloo E; Kinahan D; Mishra R; Torres Delgado SM; Kido H; Saha S; Ducrée J; Madou M; Land K; Korvink JG
    Micromachines (Basel); 2016 Jan; 7(2):. PubMed ID: 30407395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerability of point-of-care test reagents and instruments to environmental stresses: implications for health professionals and developers.
    Louie RF; Ferguson WJ; Curtis CM; Vy JH; Kost GJ
    Clin Chem Lab Med; 2014 Mar; 52(3):325-35. PubMed ID: 24114917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond.
    Alamolhoda SZ; Zarghami N; Kahroba H; Mehdipour A; Pourhassan-Moghaddam M; Jahanban-Esfahlan R; Milani M
    Adv Pharm Bull; 2022 Jan; 12(1):58-76. PubMed ID: 35517891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-reagents dispensing centrifugal microfluidics for point-of-care testing.
    Xiao Y; Li S; Pang Z; Wan C; Li L; Yuan H; Hong X; Du W; Feng X; Li Y; Chen P; Liu BF
    Biosens Bioelectron; 2022 Jun; 206():114130. PubMed ID: 35245866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for Engineering Affordable Technologies for Point-of-Care Diagnostics of Infectious Diseases.
    Zamani M; Furst AL; Klapperich CM
    Acc Chem Res; 2021 Oct; 54(20):3772-3779. PubMed ID: 34612619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic platform towards point-of-care diagnostics in infectious diseases.
    Su W; Gao X; Jiang L; Qin J
    J Chromatogr A; 2015 Jan; 1377():13-26. PubMed ID: 25544727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinase polymerase amplification: Emergence as a critical molecular technology for rapid, low-resource diagnostics.
    James A; Macdonald J
    Expert Rev Mol Diagn; 2015; 15(11):1475-89. PubMed ID: 26517245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portable devices and mobile instruments for infectious diseases point-of-care testing.
    Bissonnette L; Bergeron MG
    Expert Rev Mol Diagn; 2017 May; 17(5):471-494. PubMed ID: 28343420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paper-based microfluidics for rapid diagnostics and drug delivery.
    Mao K; Min X; Zhang H; Zhang K; Cao H; Guo Y; Yang Z
    J Control Release; 2020 Jun; 322():187-199. PubMed ID: 32169536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid diagnostics on the total integrated lab-on-a-disc for point-of-care testing.
    Nguyen HV; Nguyen VD; Nguyen HQ; Chau THT; Lee EY; Seo TS
    Biosens Bioelectron; 2019 Sep; 141():111466. PubMed ID: 31254863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample-to-answer COVID-19 nucleic acid testing using a low-cost centrifugal microfluidic platform with bead-based signal enhancement and smartphone read-out.
    Soares RRG; Akhtar AS; Pinto IF; Lapins N; Barrett D; Sandh G; Yin X; Pelechano V; Russom A
    Lab Chip; 2021 Aug; 21(15):2932-2944. PubMed ID: 34114589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Simple, Low-Cost Platform for Real-Time Isothermal Nucleic Acid Amplification.
    Craw P; Mackay RE; Naveenathayalan A; Hudson C; Branavan M; Sadiq ST; Balachandran W
    Sensors (Basel); 2015 Sep; 15(9):23418-30. PubMed ID: 26389913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the Use of Compact Disc-Based Centrifugal Microfluidics for Healthcare Diagnostics at the Extreme Point of Care.
    Gilmore J; Islam M; Martinez-Duarte R
    Micromachines (Basel); 2016 Mar; 7(4):. PubMed ID: 30407426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.